| Titolo |
Pubblicato in |
Anno |
| Correction: Advice of General Practitioner, of Surgeon, of Endocrinologist, and Self-Determination: the Italian Road to Bariatric Surgery (Obesity Surgery, (2022), 32, 6, (1996-2002), 10.1007/s11695-022-06042-8) |
OBESITY SURGERY |
2022 |
| Differential involvement of myelinated and unmyelinated nerve fibers in painful diabetic polyneuropathy |
MUSCLE & NERVE |
2021 |
| Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study |
DIABETES, OBESITY AND METABOLISM |
2021 |
| Characterization of gut microbiota in patients with metabolic syndrome candidates for bariatric/metabolic surgery: preliminary findings of a multi-center prospective study |
DIABETES RESEARCH AND CLINICAL PRACTICE |
2021 |
| Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) |
JOURNAL OF TRANSLATIONAL MEDICINE |
2021 |
| Blood glucose and epicardial adipose tissue at the hospital admission as possible predictors for COVID-19 severity |
ENDOCRINE |
2021 |
| The rs45454496 (E1813K) variant in the adiposity gene ANK2 doesn't associate with obesity in Southern European subjects |
GENE REPORTS |
2021 |
| Expression of TGR5 in adipose tissue in relation to metabolic impairment and adipose tissue dysfunction in human obesity |
METABOLISM AND TARGET ORGAN DAMAGE |
2021 |
| Expression of TGR5 in adipose tissue in relation to metabolic impairment and adipose tissue dysfunction in human obesity |
METABOLISM AND TARGET ORGAN DAMAGE |
2021 |
| Relationship Between Hepatic and Systemic Angiopoietin-Like 3, Hepatic Vitamin D Receptor Expression and NAFLD in Obesity |
LIVER INTERNATIONAL |
2020 |
| Covid-19 and diabesity. When a pandemia cross another pandemia |
EATING AND WEIGHT DISORDERS |
2020 |
| Adipose tissue remodelling in obese subjects is a determinant of presence and severity of fatty liver disease |
DIABETES/METABOLISM RESEARCH AND REVIEWS |
2020 |
| Reduced biliverdin reductase-a expression in visceral adipose tissue is associated with adipocyte dysfunction and nafld in human obesity |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2020 |
| Angiopoietin-like protein 4 overexpression in visceral adipose tissue from obese subjects with impaired glucose metabolism and relationship with lipoprotein lipase |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2020 |
| Granzyme B Expression in Visceral Adipose Tissue Associates With Local Inflammation and Glyco-Metabolic Alterations in Obesity |
FRONTIERS IN IMMUNOLOGY |
2020 |
| Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors. A multicentre retrospective study (CoViDiab II) |
CARDIOVASCULAR DIABETOLOGY |
2020 |
| Relationship between hepatic and systemic angiopoietin-like 3, hepatic Vitamin D receptor expression and NAFLD in obesity |
LIVER INTERNATIONAL |
2020 |
| Reduced biliverdin reductase-a levels are associated with early alterations of insulin signaling in obesity |
BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE |
2019 |
| ANGPTL4 gene E40K variation protects against obesity-associated dyslipidemia in participants with obesity |
OBESITY SCIENCE & PRACTICE |
2019 |
| Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity |
BMC MEDICINE |
2019 |
